Antimicrobial properties of platelet-rich preparations. A systematic review of the current pre-clinical evidence

References

• Anitua E, Sanchez M, Orive G, Andia I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007;28:4551–4560.
   PubMed Web of Science ®Google Scholar
• Anitua E, Sánchez M, Orive G. Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Delivery Rev 2010;62:741–752.
   PubMed Web of Science ®Google Scholar
• Bielecki T, Dohan Ehrenfest DM. Platelet-rich plasma (PRP) and Platelet-Rich Fibrin (PRF): Surgical adjuvants, preparations for in situ regenerative medicine and tools for tissue engineering. Curr Pharm Biotechnol 2012;13:1121–1130.
   PubMed Web of Science ®Google Scholar
• El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, van Dyke TE. Platelet-rich plasma: Growth factors and pro- and anti-inflammatory properties. J Periodontol 2007;78:661–669.
   PubMed Web of Science ®Google Scholar
• Cieslik-Bielecka A, Dohan Ehrenfest DM, Lubkowska A, Bielecki T. Microbicidal properties of Leukocyte- and Platelet-Rich Plasma/Fibrin (L-PRP/L-PRF): New perspectives. J Biol Regul Homeost Agents 2012;26( Suppl 1): 43S–52S.
   Google Scholar
• Anitua E, Alonso R, Girbau C, Aguirre JJ, Murozabal F, Orive G. Antibacterial effect of plasma rich in growth factors (PRGF-Endoret) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol 2012;37:652–657.
   PubMed Web of Science ®Google Scholar
• Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:638–646.
   PubMed Web of Science ®Google Scholar
• Anitua E. Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999;14:529–535.
   PubMed Web of Science ®Google Scholar
• Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004;91:4–15.
   PubMed Web of Science ®Google Scholar
• Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leukocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009;27:158–167.
   PubMed Web of Science ®Google Scholar
• Hirsch JG. Comparative bactericidal activities of blood serum and plasma serum. J Exp Med 1960;112:15–22.
   PubMed Web of Science ®Google Scholar
• Wecksler BB, Nachman RL. Rabbit platelet bactericidal protein. J Exp Med 1971;134:1114–1130.
   PubMed Web of Science ®Google Scholar
• Hamzeh-Cognasse H, Damien P, Chabert A, Pozzetto B, Cognasse F, Garraud O. Platelets and infections – Complex interactions with bacteria. Front Immunol 2015;6:82. doi:10.3389/fimmu.2015.00082.
   Web of Science ®Google Scholar
• Yeaman MR, Norman DC, Bayer AS. Staphylococcus aureus susceptibility to thrombin-induced platelet microbicidal protein is independent of platelet adherence and aggregation in vitro. Infect Immun 1992;60:2368–2374.
   PubMed Web of Science ®Google Scholar
• Yeaman MR, Puentes SM, Norman DC, Bayer AS. Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infect Immun 1992;60:1202–1209.
   PubMed Web of Science ®Google Scholar
• Yeaman MR, Ibrahim AS, Edwards JE Jr, Bayer AS, Ghannoum MA. Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro. Antimicrob Agents Chemother 1993;37:546–553.
   PubMed Web of Science ®Google Scholar
• Yeaman MR, Tang YQ, Shen AJ, Bayer AS, Selsted ME. Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun 1997;65:1023–1031.
   PubMed Web of Science ®Google Scholar
• Krijgsveld J, Zaat SA, Meeldijk J, van Veelen PA, Fang G, Poolman B, Brandt E, Ehlert JE, Kuijpers AJ, Engbers GH, et al. Thrombocidines, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem 2000;275:20374–20381.
   PubMed Web of Science ®Google Scholar
• Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun 2002;70:6524–6533.
   PubMed Web of Science ®Google Scholar
• Yeaman MR. The role of platelets in antimicrobial host defense. Clin Infect Dis 1997;25:951–968.
   PubMed Web of Science ®Google Scholar
• Jenne CN, Kubes P. Platelets in inflammation and infection. Platelets 2015;26:286–292.
   PubMed Web of Science ®Google Scholar
• Ríos DL, López C, Carmona JU. Platelet-rich gel supernatants stimulate the release of anti-inflammatory proteins on culture media of normal equine synovial membrane explants. Vet Med Int 2015;2015: 547052.
   Google Scholar
• Krithikadatta J, Gopikrishna V, Datta M. CRIS Guidelines (Checklist for Reporting In-vitro Studies): A concept note on the need for standardized guidelines for improving quality and transparency in reporting in-vitro studies in experimental dental research. J Conserv Dent 2014;17:301–304.
   PubMedGoogle Scholar
• Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biol 2010;8(6):e1000412. doi:10.1371/journal.pbio.1000412
   PubMed Web of Science ®Google Scholar
• Trowbridge CC, Stammers AH, Woods E, Yen BR, Klayman M, Gilbert C. Use of platelet gel and its effects on infection in cardiac surgery. J Extra Corpor Technol 2005;37:381–386.
   PubMedGoogle Scholar
• Englert SJ, Estep TH, Ellis-Stoll CC. Postoperative surgical chest and leg incision sites using platelet gel: A retrospective study. J Extra Corpor Technol 2008;40:225–228.
   PubMedGoogle Scholar
• Cieslik-Bielecka A, Bielecki T, Gazdzik TS, Arendt J, Krol W, Szczepanski T. Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury. Transfus Apher Sci 2009;41:9–12.
   PubMed Web of Science ®Google Scholar
• Kachel E, Callum J, Moussa F, Goldstein J, Fremes S. Treatment of deep sternal wound infections after coronary artery bypass grafting by means of injection of platelet gel: An evolving technology. J Thorac Cardiovasc Surg 2010;139:e118–120.
   PubMed Web of Science ®Google Scholar
• Cieslik-Bielecka A, Gazdzik TS, Bielecki TM, Cieslik T. Why the platelet-rich gel has antimicrobial activity? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:303–305.
   PubMed Web of Science ®Google Scholar
• Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Krol W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: An in vitro study. J Bone Joint Surg Br 2007;89:417–420.
   PubMed Web of Science ®Google Scholar
• Moojen DJ, Everts PA, Schure RM, Overdevest EP, van Zundert A, Knape JT, Castelein RM, Creemers LB, Dhert WJ. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res 2008;26:404–410.
   PubMed Web of Science ®Google Scholar
• Yang Y, Liu H, Liu G, Ran X. Antibacterial effect of autologous platelet-rich gel derived from health volunteers in vitro. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2010;24:571–576.
   PubMedGoogle Scholar
• Álvarez ME, López C, Giraldo CE, Samudio I, Carmona JU. In vitro bactericidal activity of equine platelet concentrates, platelet poor plasma, and plasma against methicillin-resistant Staphylococcus aureus. Arch Med Vet 2011;43:155–161.
   Web of Science ®Google Scholar
• Tohidnezhad M, Varoga D, Podschun R, Wruck CJ, Seekamp A, Brandenburg LO, Pufe T, Lippross S. Thrombocytes are effectors of the innate immune system releasing human beta defensin-3. Injury 2011;42:682–686.
   PubMed Web of Science ®Google Scholar
• Tohidnezhad M, Varoga D, Wruck CJ, Podschun R, Sachweh BH, Bornemann J, Bovi M, Sönmez TT, Slowik A, Houben A, et al. Platelets display potent antimicrobial activity and release human beta-defensin 2. Platelets 2012;23:217–223.
   PubMed Web of Science ®Google Scholar
• Wu X, Ren J, Yuan Y, Luan J, Yao G, Li J. Antimicrobial properties of single-donor-derived, platelet-leukocyte fibrin for fistula occlusion: An in vitro study. Platelets 2013;24:632–636.
   PubMed Web of Science ®Google Scholar
• Rozalski MI, Micota B, Paszkiewicz M, Wieckowoska-Szakiel M, Rozalska B. Antimicrobial/anti-biofilm activity of expired blood platelets and their released products. Postepy Hig Med Dosw 2013;67:321–325.
   Web of Science ®Google Scholar
• Li H, Li B. PRP as a new approach to prevent infection: Preparation and in vitro antimicrobial properties of PRP. J Vis Exp 2013;74. doi:10.3791/50351.
   Web of Science ®Google Scholar
• Drago L, Bortolin M, Vassena C, Taschieri S, Del Fabbro M. Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity. BMC Microbiol 2013;13:47. doi:10.1186/1471-2180-13-47
   PubMed Web of Science ®Google Scholar
• Aktan I, Dunkel B, Cunningham FM. Equine platelets inhibit Escherichia coli growth and can be activated by bacterial lipopolysaccharide and lipoteichoic acid although superoxide anion production does not occur and platelet activation is not associated with enhanced production by neutrophils. Vet Immunol Immunopathol 2013;152:209–217.
   PubMed Web of Science ®Google Scholar
• Burnouf T, Chou ML, Wu YW, Su CY, Lee LW. Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria. Transfusion 2013;53:138–146.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang C, Liu H, Liu G, Ran X. Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro. J Diabetes Res 2013;2013: 269527. doi:10.1155/2013/269527.
   Web of Science ®Google Scholar
• Edelblute CM, Donate AL, Hargrave BY, Heller LC. Human platelet gel supernatant inactivates opportunistic wound pathogens on skin. Platelets 2015;26:13–16.
   PubMed Web of Science ®Google Scholar
• Intravia J, Allen DA, Durant TJ, McCarthy MB, Russell R, Beitzel K, Cote MP, Dias F, Mazzocca AD. In vitro evaluation of the anti-bacterial effect of two preparations of platelet rich plasma compared with cefazolin and whole blood. Muscles Ligaments Tendons J 2014;4:79–84.
   PubMedGoogle Scholar
• Mariani E, Filardo G, Canella V, Berlingeri A, Bielli A, Cattini L, Landini MP, Kon E, Marcacci M, Facchini A. Platelet-rich plasma affects bacterial growth in vitro. Cytotherapy 2014;16:1294–1304.
   PubMed Web of Science ®Google Scholar
• Drago L, Bortolin M, Vassena C, Romanò CL, Taschieri S, Del Fabbro M. Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma: An in vitro study. PLoS One 2014;9(9): e107813. doi:10.1371/journal.pone.0107813.
   Web of Science ®Google Scholar
• Yang LC, Hu SW, Yan M, Yang JJ, Tsou SH, Lin YY. Antimicrobial activity of platelet-rich plasma and other plasma preparations against periodontal pathogens. J Periodontol 2015;86:310–318.
   PubMed Web of Science ®Google Scholar
• Jia W, Zhang C, Wang J, Chen J, Jiang Y. An experimental study on antimicrobial efficacy of platelet-rich plasma for bone infection prophylaxis. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2010;24:864–870.
   PubMedGoogle Scholar
• Jia WT, Zhang CQ, Wang JQ, Feng Y, Ai ZS. The prophylactic effects of platelet-leucocyte gel in osteomyelitis: An experimental study in a rabbit model. J Bone Joint Surg Br 2010;92:304–310.
   PubMedGoogle Scholar
• Li H, Hamza T, Tidwell JE, Clovis N, Li B. Unique antimicrobial effects of platelet-rich plasma and its efficacy as a prophylaxis to prevent implant-associated spinal infection. Adv Healthcare Mater 2013;2:1277–1284.
   Web of Science ®Google Scholar
• Li GY, Yin JM, Ding H, Jia WT, Zhang CQ. Efficacy of leukocyte- and platelet-rich plasma gel (L-PRP gel) in treating osteomyelitis in a rabbit model. J Orthop Res 2013;31:949–956.
   PubMed Web of Science ®Google Scholar
• Mariani E, Canella V, Berlingeri A, Cattini L, Landini MP, Kon E, Marcacci M, Di Matteo B, Filardo G. Leukocyte presence does not increase microbicidal activity of Platelet-rich Plasma in vitro. BMC Microbiol 2015;15:149.
   PubMed Web of Science ®Google Scholar
• Yuan T, Zhang CQ, Zeng BF. Treatment of chronic femoral osteomyelitis with platelet-rich plasma (PRP): A case report. Transfus Apher Sci 2008;38:167–170.
   PubMed Web of Science ®Google Scholar
• Fodor, J. Die Fahigkeit des Blutes. Bakterien zu vernichten. Dtsch Med Wochenschr 1887;13:745–747.
   Google Scholar
• Kerrigan SW. The expanding field of platelet-bacterial interconnections. Platelets 2015;26:293–301.
   PubMed Web of Science ®Google Scholar
• Shannon O. Platelet interaction with bacterial toxins and secreted products. Platelets 2015;26:302–308.
   PubMed Web of Science ®Google Scholar
• McNicol A. Bacteria-induced intracellular signaling in platelets. Platelets 2015;26:309–316.
   PubMed Web of Science ®Google Scholar
• Lu HJ, Chen TL, Zhang XH, Liu J, Bao HW. Antibacterial effects of platelet-rich plasma in promoting facial scars healing in combination with adipose-derived stromal vascular fraction cells. J Craniofac Surg 2015;26:e670–672.
   Google Scholar